Home › Funds › Point72 Asset Management › ERAS
Point72 Asset Management position in ERAS
ERASCA INC · Health Care
Latest position (Q2 2026)1.25M sh
Reported value held$22.85M
Portfolio Weight0.03%
First reportedQ1 2023
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2023 | 35.50K | $106.85K | New |
| Q1 2024 | 1.10M | $2.26M | New |
| Q2 2024 | 1.04M | $2.44M | Reduce |
| Q3 2024 | 63.60K | $173.62K | Reduce |
| Q1 2025 | 40.52K | $55.52K | New |
| Q1 2026 | 693.31K | $11.22M | New |
| Q2 2026 | 1.25M | $22.85M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding ERAS
- BlackRock Inc 21.15M sh · $387.54M · Q2 2026
- Geode Capital Management 6.50M sh · $119.13M · Q2 2026
- Goldman Sachs Group 3.82M sh · $70.02M · Q2 2026
- Janus Henderson Group 3.71M sh · $59.99M · Q1 2026
- Bank of America Corp 3.05M sh · $55.85M · Q2 2026
- Fidelity Management & Research (FMR) 2.88M sh · $52.82M · Q2 2026
- Vanguard Group 12.81M sh · $47.66M · Q4 2025
- Northern Trust Corp 1.96M sh · $35.87M · Q2 2026
- Charles Schwab Investment Management 1.94M sh · $35.63M · Q2 2026
- UBS Group AG 1.60M sh · $29.25M · Q2 2026
- Renaissance Technologies 1.37M sh · $25.08M · Q2 2026
- Balyasny Asset Management 1.26M sh · $23.05M · Q2 2026